| Literature DB >> 30451915 |
Fiona D'Souza1, Shubhashree Uppangala1, Gitanjali Asampille2,3, Sujith Raj Salian1, Guruprasad Kalthur1, Riccardo Talevi4, Hanudatta S Atreya5,6, Satish Kumar Adiga7.
Abstract
The metabolomic profile of an embryo culture medium can aid in the advanced prediction of embryonic developmental potential and genetic integrity. But it is not known if this technology can be used to determine the in vitro potential of inner cell mass (ICM) in adherence and proliferation. Here, we investigated the developmental potential of mouse 2-cell embryos carrying cisplatin-induced DNA lesions (IDL), beyond blastocyst stage using ICM outgrowth assay. The genetic integrity of ICM cells was determined by comet assay. The metabolic signatures of spent medium were recorded 84 hours post injection of hCG (hpi-hCG), and after 96 hours of extended in vitro culture (Ex 96) by NMR spectroscopy. We observed that blastocysts that lack the ability to adhere in vitro had an increased requirement of pyruvate (p < 0.01), lactate (p < 0.01), and were accompanied by a significant reduction of pyruvate-alanine ratio in the culture medium. We propose that the aforementioned metabolites from 84 hpi-hCG spent medium be further explored using appropriate experimental models, to prove their potential as biomarkers in the prediction of implantation ability of in vitro derived human embryos in clinical settings.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30451915 PMCID: PMC6242932 DOI: 10.1038/s41598-018-35342-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Representative phase contrast images of inner cell mass (ICM) outgrowths on Ex 96 in control (left panel) and IDL group (right panel). Arrow head marks ICM outgrowths (Scale bar 25 µm). (b) Quantification of ICM area on Ex 96. ICM area was significantly reduced (p < 0.01) in Completely developed ICM Outgrowth (CIO) and Large ICM Outgrowth (LIO) derived from IDL embryos in relation to corresponding control group (c) ICM to trophectoderm (TE) area ratio on Ex 96 was significantly reduced (p < 0.0001) in CIO and LIO derived from IDL embryos compared to control.
Potential of IDL embryos to develop ICM outgrowths on Ex 96.
| ICM grades | Completely developed outgrowth | Large outgrowth (LIO) | Small outgrowth (SIO) | No outgrowth (NIO) |
|---|---|---|---|---|
| Control (N) | 36.7% | 17.87% | 11.5% | 10.62% |
| IDL (N) | 25%* | 23.14% | 14.35% | 18.05%* |
*p < 0.05, vs control.
Figure 2(a) Olive tail moment (OTM). Control (N = 13) and IDL group (N = 13) in Ex 96 outgrowths. (b) Relative mRNA expression of regulators of apoptosis. Expression of Bax was significantly reduced (p < 0.05) in IDL group. Light brown bars represent the control and red bars represent the IDL group. Data is represented as Mean ± SEM.
Figure 3Uptake of metabolites ((a) lactate; (b) pyruvate; (c) alanine; (d) pyruvate to alanine ratio) in 84 hpi-hCG spent media of embryos in relation to attachment potential on Ex 24. In total, control N = 54, IDL N = 52 and medium control N = 12 84 hpi-hCG spent media samples were analyzed based on their attachment potential on Ex 24. Light brown bars represent attached (Control N = 33, IDL N = 33) and red bars represent unattached embryos (Control N = 21, IDL N = 19). Data represented as Mean ± SEM.
Relative intensities of metabolites (normalized with respect to TSP) in spent culture medium on Ex 96 in relation to ICM developmental potential on Ex 96.
| Control | IDL | |||
|---|---|---|---|---|
| CIO N = 26 | NIO N = 14 | CIO N = 23 | NIO N = 13 | |
| Glucose | 3.96 ± 0.10 | 3.96 ± 0.19 | 2.88 ± 0.21** | 3.43 ± 0.28 |
| Lactate | 4.57 ± 0.06 | 4.63 ± 0.05 | 4.66 ± 0.11 | 4.65 ± 0.20 |
| Phenylalanine | 0.37 ± 0.01 | 0.36 ± 0.01 | 0.35 ± 0.02 | 0.33 ± 0.02 |
| Tyrosine | 0.25 ± 0.01 | 0.24 ± 0.01 | 0.26 ± 0.05 | 0.22 ± 0.01 |
| Threonine | 0.28 ± 0.01 | 0.28 ± 0.01 | 0.24 ± 0.01 | 0.25 ± 0.01 |
| Lysine | 0.75 ± 0.01 | 0.73 ± 0.02 | 0.71 ± 0.02 | 0.74 ± 0.02 |
| Methionine | 0.14 ± 0.01 | 0.14 ± 0.01 | 0.12 ± 0.01 | 0.11 ± 0.01 |
| Glutamine | 2.59 ± 0.04 | 2.59 ± 0.05 | 2.43 ± 0.06 | 2.43 ± 0.08 |
| Alanine | 0.47 ± 0.01 | 0.47 ± 0.01 | 0.48 ± 0.01 | 0.48 ± 0.02 |
| Valine | 0.84 ± 0.02 | 0.82 ± 0.02 | 0.81 ± 0.02 | 0.80 ± 0.03 |
| Isoleucine | 0.80 ± 0.02 | 0.79 ± 0.02 | 0.76 ± 0.02 | 0.76 ± 0.03 |
**p < 0.001 vs control.
Figure 4Overview of the experimental design.